Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
4 participants
INTERVENTIONAL
2008-02-29
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease
NCT04018092
Low Level Laser Therapy Impact on Cognitive Function and Quality of Life in Alzheimer Anemic Elderly Patients
NCT04496778
Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
NCT01819714
Effect of Therapeutic Light on Sleep, Circadian Rhythm, and Global Function in Women With Alzheimer's
NCT02502045
Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2
NCT05837819
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Far Infrared Radiation
Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared radiation for 30 to 40 minutes per treatment session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Far Infrared Radiation (5μm to 20μm wavelength)
Far Infrared radiation for 30 to 40 minutes per treatment session.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GAAD Medical Research Institute Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GAAD Medical Research Institute Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ken Nedd, M.D.
Role: PRINCIPAL_INVESTIGATOR
GAAD Medical Research Institute Inc.
Kwasi Donyina, Ph.D.
Role: STUDY_DIRECTOR
GAAD Medical Research Institute Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Centre for Incurable Diseases
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GAAD-AD-CTP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.